Concourse Financial Group Securities, Inc. Argenx Se Transaction History

Concourse Financial Group Securities, Inc.

$0
Q2 2025

Number of Shares

Previous 0 NaN%

Holding current value

Previous $0 NaN%

% of portfolio

100.0%

Previous 100.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 12, 2025	BUY	$532.27 - $656.65 $0 - $0	0 New	0 $0
Q1 2025 May 14, 2025	SELL	$571.0 - $671.75 $571 - $671	-1 Closed	0 $0
Q1 2024 Apr 30, 2024	BUY	$356.95 - $413.29 $356 - $413	1 New	1 $0
Q4 2023 Feb 07, 2024	BUY	$338.91 - $506.01 $0 - $0	0 New	0 $0
Q3 2023 Oct 30, 2023	BUY	$369.35 - $548.43 $0 - $0	0 New	0 $0

Q3 2023 Oct 25, 2023	BUY	$369.35 - $548.43 $0 - $0	0 New	0 $0
Q2 2023 Aug 10, 2023	BUY	$360.14 - $422.58 $0 - $0	0 New	0 $0
Q1 2023 May 15, 2023	BUY	$334.23 - $403.65 $0 - $0	0 New	0 $0
Q4 2022 Jan 30, 2023	BUY	$342.17 - $402.31 $0 - $0	0 New	0 $0
Q3 2022 Nov 15, 2022	BUY	$343.2 - $395.75 $0 - $0	0 New	0 $0
Q2 2022 Aug 09, 2022	BUY	$269.58 - $378.88 $0 - $0	0 New	0 $0
Q1 2022 May 09, 2022	BUY	$254.45 - $351.06 $0 - $0	0 New	0 $0
Q4 2021 Feb 07, 2022	BUY	$272.01 - $353.03 $0 - $0	0 New	0 $0
Q3 2021 Nov 09, 2021	BUY	$295.0 - $350.58 $0 - $0	0 New	0 $0
Q2 2021 Aug 13, 2021	BUY	$257.11 - $319.92 $0 - $0	0 New	0 $0
Q1 2021 May 13, 2021	BUY	$268.3 - $380.31 $0 - $0	0 New	0 $0
Q4 2020 Feb 02, 2021	SELL	$248.13 - $308.36 $1,985 - $2,466	-8 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$106.59 - $164.21 $852 - $1,313	8 New	8 $1,000
Q3 2019 Nov 13, 2019	BUY	$113.31 - $150.51 $0 - $0	0 New	0 $0
Q2 2019 Aug 13, 2019	BUY	$115.0 - $141.58 $0 - $0	0 New	0 $0
Q1 2019 May 15, 2019	BUY	$98.85 - $134.59 $0 - $0	0 New	0 $0
Q4 2018 Feb 14, 2019	BUY	$63.81 - $109.82 $0 - $0	0 New	0 $0
Q3 2018 Nov 13, 2018	BUY	$75.5 - $96.63 $0 - $0	0 New	0 $0

Others Institutions Holding ARGX

# of Institutions

525

Shares Held

26M

Call Options Held

589K

Put Options Held

320K

Price T Rowe Associates Inc Baltimore, MD

3.64M
Shares

$3.31 Billion
0.29% of portfolio
Janus Henderson Group PLC London, X0

2.58M
Shares

$2.34 Billion
0.92% of portfolio
Artisan Partners Limited Partnership Milwaukee, WI

2.19M
Shares

$1.99 Billion
2.46% of portfolio
Capital World Investors Los Angeles, CA

1.96M
Shares

$1.78 Billion
0.21% of portfolio
Black Rock Inc. New York, NY

1.01M
Shares

$918 Million
0.01% of portfolio

View Full List

About ARGENX SE

Ticker ARGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,323,800
Market Cap $50.2B
Description
argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...

More about ARGX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Account